The safety of drotrecogin alfa (activated) in pediatric patients with severe sepsis

被引：1
|
作者：
Goldstein, B
Williams, M
Wang, DZ
Angle, R
Giroir, B
机构：
[1] Oregon Hlth Sci Univ, Portland, OR 97201 USA
[2] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
[3] DARPA, Arlington, VA USA
来源：
CRITICAL CARE MEDICINE | 2005年 / 33卷 / 12期
关键词：
D O I：
10.1097/00003246-200512002-00536
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：A152 / A152
页数：1
相关论文
共 50 条
  • [1] Drotrecogin alfa activated as a treatment for severe sepsis in pediatric cancer
    Russo, G.
    La Spina, M.
    Disma, N.
    Astuto, M.
    [J]. BONE MARROW TRANSPLANTATION, 2006, 38 (08) : 575 - 576
  • [2] The efficacy of drotrecogin alfa (activated) for the treatment of pediatric severe sepsis
    Giroir, B
    Goldstein, B
    Nadel, S
    Wang, DZ
    Levy, H
    Williams, M
    [J]. CRITICAL CARE MEDICINE, 2005, 33 (12) : A152 - A152
  • [3] Drotrecogin alfa activated as a treatment for severe sepsis in pediatric cancer
    G Russo
    M La Spina
    N Disma
    M Astuto
    [J]. Bone Marrow Transplantation, 2006, 38 : 575 - 576
  • [4] Drotrecogin alfa (activated) in severe sepsis
    Baillie, JK
    Murray, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (01): : 95 - 95
  • [5] Drotrecogin alfa (activated) in severe sepsis
    Janes, Jonathan M.
    Vangerow, Burkhard
    Costigan, Timothy M.
    Macias, William L.
    [J]. LANCET INFECTIOUS DISEASES, 2013, 13 (02): : 108 - 109
  • [6] Safety assessment of drotrecogin alfa (activated) in the treatment of adult patients with severe sepsis
    Gordon R Bernard
    William L Macias
    David E Joyce
    Mark D Williams
    Joan Bailey
    Jean-Louis Vincent
    [J]. Critical Care, 7
  • [7] Safety assessment of drotrecogin alfa (activated) in the treatment of adult patients with severe sepsis
    Bernard, GR
    Macias, WL
    Joyce, DE
    Williams, MD
    Bailey, J
    Vincent, JL
    [J]. CRITICAL CARE, 2003, 7 (02) : 155 - 163
  • [8] Safety, pharmacokinetics, and pharmacodynamics of drotrecogin alfa (activated) in children with severe sepsis
    Weiss, KD
    [J]. PEDIATRICS, 2004, 113 (01) : 134 - 134
  • [9] Drotrecogin alfa (activated) treatment of older patients with severe sepsis
    Ely, EW
    Angus, DC
    Williams, MD
    Bates, B
    Qualy, R
    Bernard, GR
    [J]. CLINICAL INFECTIOUS DISEASES, 2003, 37 (02) : 187 - 195
  • [10] Introduction: severe sepsis and drotrecogin alfa (activated)
    Artigas, Antonio
    Martin, Claude D.
    [J]. CRITICAL CARE, 2007, 11 (Suppl 5)
12345